ETFs
V
VRTX
Vertex Pharmaceuticals Inc
441.20
+5.55+1.27%After Hours: 443.50 +2.30 +0.52%19:52 04/17 EDT
OPEN/PREV CLOSE441.55/435.65
TODAY RANGE437.58-443.90
VOL1.03M
MARKET CAP112.22B
52 WEEK RANGE362.50-510.77
AVG VOL (3M)1.45M
% TURNOVER0.40%
TURNOVER--
P/E (TTM)28.79
% RANGE1.45%
EPS(TTM)15.32
P/E(FORWARD)25.94
P/B6.00
BVPS73.49
DIVIDEND--
P/S9.34
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP111.97B
SHARES OUTSTANDING254.36M
NEXT EARNINGS05/04-05/08
FREE FLOAT253.79M
LOT SIZE1
EX-DATE08/24/2000
News
Press Releases
Financial Reports
Profile
Simply Wall St·2h ago
Is Vertex Pharmaceuticals (VRTX) Offering Value After Recent Pipeline Milestones And Mixed Share Performance?
The Motley Fool·2d ago
Is Vertex Pharmaceuticals' Empire in Trouble?
TipRanks·2d ago
Trump names Erica Schwartz CDC Director
Simply Wall St·4d ago
The Bull Case For Vertex Pharmaceuticals (VRTX) Could Change Following Major CFTR Therapy Label Expansion Approval
Simply Wall St·04/12 00:36
Is It Time To Revisit Vertex Pharmaceuticals (VRTX) After The Recent Share Price Pullback?
Dow Jones·04/10 16:22
Vertex Pharmaceuticals Is Maintained at Overweight by Morgan Stanley
TipRanks·04/10 12:58
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
TipRanks·04/10 12:28
Vertex Pharmaceuticals (VRTX) Receives a Buy from Morgan Stanley
Same Industry
Name/Symbol
Change%
Price